Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Becton Dickinson and Co (NYSE:BDX)

182.49
Delayed Data
As of 12:36pm ET
 +0.19 / +0.10%
Today’s Change
144.73
Today|||52-Week Range
182.86
+10.23%
Year-to-Date
Why Accelerate Diagnostics Inc Is Soaring Today
12:22pm / MotleyFool.com - Paid Partner Content
Becton, Dickinson Launches BD Resolve Early Access Program
Feb 14 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close182.30
Today’s open181.98
Day’s range181.14 - 182.86
Volume227,447
Average volume (3 months)1,101,650
Market cap$38.8B
Dividend yield1.60%
Data as of 12:36pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+34.03%
Earnings growth (this year)+9.72%
Earnings growth (next 5 years)+10.08%
Revenue growth (last year)+21.41%
P/E ratio30.4
Price/Sales3.13
Price/Book5.09

Competitors

 Today’s
change
Today’s
% change
BSXBoston Scientific Co...+0.24+0.98%
ZBHZimmer Biomet Holdin...+0.52+0.45%
BCRC R Bard Inc+0.90+0.37%
TFXTeleflex Inc+5.36+2.91%
Data as of 12:51pm ET, 02/24/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)$2.23
Annual revenue (last year)$12.5B
Annual profit (last year)$976.0M
Net profit margin7.82%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Vincent A. Forlenza
EVP, Chief Financial &
Administrative Officer
Christopher R. Reidy
Corporate headquarters
Franklin Lakes, New Jersey

Forecasts


Search for Jobs